Virax Biolabs Group Ltd. Class A's total assets for Q4 2024 were $5.48M, a decrease of -21.94% from the previous quarter. VRAX total liabilities were $345.19K for the fiscal quarter, a -62.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.